| Online: | |
| Visits: | |
| Stories: |
| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
What Do Monsanto, Tekmira And The Ebola Virus Have In Common?
by NTEB Health and Wellness Editor Stephanie A. Buist, ND HC
Looking into the eye of the perfect storm
“My people are destroyed for lack of knowledge: because thou hast rejected knowledge, I will also reject thee, that thou shalt be no priest to me: seeing thou hast forgotten the law of thy God, I will also forget thy children.” Hosea 4:6
Just when we thought this nightmare couldn’t get any worse, now we find out that Monsanto has invested $1.5 Million in the Canadian pharmaceutical company for “specific development” of the agriculture RNAi project. The press release states:
The development milestone is part of the research program under the Option Agreement Tekmira signed with the agriculture company, which we announced on January 13, 2014. The Option Agreement relates to Tekmira’s proprietary delivery technology and intellectual property for use in agricultural applications. The potential value of the transaction could reach up to $86.2 million, following the successful completion of all program milestones.
Tekmira is the pharmaceutical company that has been working on the serum to treat Ebola. As I reported in my previous article on Ebola, the serum trial had been placed on hold while executives gathered information about how the drug works in the body per the request of the FDA.
Will you be one of the first Americans to participate in the trial vaccination program for Ebola if offered to you?
Another press release about Tekmira reveals a $140 million contract with the U.S. military for Ebola treatment drugs:
TKM-Ebola, an anti-Ebola virus RNAi therapeutic, is being developed uner a $140 million contract from the U.S. Department of Defense’s Medical Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product Management Office.
In my previous article I reported that the TKM-Ebola project had been put on hold in July. However, now on August 7 , it has been reported that the FDA has placed the project on “partial hold”. This change in status will enable the potential use of the TKM-Ebola in cases where individuals have been infected with Ebola virus.
This is not the product that was given to the 2 doctors that are now residing at Emory University Hospital. They were given a different product called ZMapp from Kentucky BioProcessing . It was announced on August 7, 2014 that the FDA has lifted the hold on this experimental drug… CLICK HERE to read the rest of this story on Stepping Stones Living
The post What Do Monsanto, Tekmira And The Ebola Virus Have In Common? appeared first on Now The End Begins.
Source: http://www.nowtheendbegins.com/blog/?p=24084
you need better glue, to actually piece together a coherent story. That press statement is an agriculture project. That has nothing to do with ebola. Ebola isn’t food last time I checked.
also RNA is a polymer produced by all living things to help translate genetic information stored in DNA into functional proteins. It is single stranded and chemically different from DNA.
Also any kind of anti viral medication uses RNA Inhibitors. Like integrase inhibitors, protease inhibitors, transcription inhibitors. It is the only way to stop the virus from merging its RNA to the cells DNA which converts the cell in a virus factory.
and how you come back from Tekmira to montsanto, i donno… since they do totally different in what they are doing.
Had you done any research at all, you wouldn’t have opened your mouth!! You’re a lazy imbecile who want’s it all spoonfed to you!!
You are obviously completely oblivious as to what the heinous ramifications of what the story encompasses! Sadly you’re parents procreated and the resultant troglodyte is less than useless!